Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 27

1.

Enhanced growth of seed viruses for H5N1 influenza vaccines.

Horimoto T, Murakami S, Muramoto Y, Yamada S, Fujii K, Kiso M, Iwatsuki-Horimoto K, Kino Y, Kawaoka Y.

Virology. 2007 Sep 15;366(1):23-7. Epub 2007 Jul 24.

2.

Yield increases in intact influenza vaccine virus from chicken allantoic fluid through isolation from insoluble allantoic debris.

Hughes K, Zachertowska A, Wan S, Li L, Klimaszewski D, Euloth M, Hatchette TF.

Vaccine. 2007 May 30;25(22):4456-63. Epub 2007 Mar 26.

PMID:
17418461
3.

Safety and immunogenicity of an inactivated subvirion influenza A (H5N1) vaccine.

Treanor JJ, Campbell JD, Zangwill KM, Rowe T, Wolff M.

N Engl J Med. 2006 Mar 30;354(13):1343-51.

4.

The polymerase complex genes contribute to the high virulence of the human H5N1 influenza virus isolate A/Vietnam/1203/04.

Salomon R, Franks J, Govorkova EA, Ilyushina NA, Yen HL, Hulse-Post DJ, Humberd J, Trichet M, Rehg JE, Webby RJ, Webster RG, Hoffmann E.

J Exp Med. 2006 Mar 20;203(3):689-97. Epub 2006 Mar 13.

5.

The development and characterization of H5 influenza virus vaccines derived from a 2003 human isolate.

Horimoto T, Takada A, Fujii K, Goto H, Hatta M, Watanabe S, Iwatsuki-Horimoto K, Ito M, Tagawa-Sakai Y, Yamada S, Ito H, Ito T, Imai M, Itamura S, Odagiri T, Tashiro M, Lim W, Guan Y, Peiris M, Kawaoka Y.

Vaccine. 2006 Apr 24;24(17):3669-76. Epub 2005 Jul 21.

PMID:
16378663
6.

Neuraminidase is important for the initiation of influenza virus infection in human airway epithelium.

Matrosovich MN, Matrosovich TY, Gray T, Roberts NA, Klenk HD.

J Virol. 2004 Nov;78(22):12665-7.

7.

From lethal virus to life-saving vaccine: developing inactivated vaccines for pandemic influenza.

Wood JM, Robertson JS.

Nat Rev Microbiol. 2004 Oct;2(10):842-7. Review.

PMID:
15378048
9.
11.
12.

Balanced hemagglutinin and neuraminidase activities are critical for efficient replication of influenza A virus.

Mitnaul LJ, Matrosovich MN, Castrucci MR, Tuzikov AB, Bovin NV, Kobasa D, Kawaoka Y.

J Virol. 2000 Jul;74(13):6015-20.

13.

A DNA transfection system for generation of influenza A virus from eight plasmids.

Hoffmann E, Neumann G, Kawaoka Y, Hobom G, Webster RG.

Proc Natl Acad Sci U S A. 2000 May 23;97(11):6108-13.

14.
15.

Avirulent Avian influenza virus as a vaccine strain against a potential human pandemic.

Takada A, Kuboki N, Okazaki K, Ninomiya A, Tanaka H, Ozaki H, Itamura S, Nishimura H, Enami M, Tashiro M, Shortridge KF, Kida H.

J Virol. 1999 Oct;73(10):8303-7.

16.

Generation of influenza A viruses entirely from cloned cDNAs.

Neumann G, Watanabe T, Ito H, Watanabe S, Goto H, Gao P, Hughes M, Perez DR, Donis R, Hoffmann E, Hobom G, Kawaoka Y.

Proc Natl Acad Sci U S A. 1999 Aug 3;96(16):9345-50.

17.

Characterization of avian H5N1 influenza viruses from poultry in Hong Kong.

Shortridge KF, Zhou NN, Guan Y, Gao P, Ito T, Kawaoka Y, Kodihalli S, Krauss S, Markwell D, Murti KG, Norwood M, Senne D, Sims L, Takada A, Webster RG.

Virology. 1998 Dec 20;252(2):331-42.

18.

Characterization of an avian influenza A (H5N1) virus isolated from a child with a fatal respiratory illness.

Subbarao K, Klimov A, Katz J, Regnery H, Lim W, Hall H, Perdue M, Swayne D, Bender C, Huang J, Hemphill M, Rowe T, Shaw M, Xu X, Fukuda K, Cox N.

Science. 1998 Jan 16;279(5349):393-6.

19.

Influenza virus hemagglutinin and neuraminidase cytoplasmic tails control particle shape.

Jin H, Leser GP, Zhang J, Lamb RA.

EMBO J. 1997 Mar 17;16(6):1236-47.

Supplemental Content

Support Center